Sessions selected on Jan 30 Meeting

Update from Jan 30 Organizational meeting:

• 35 sessions were voted in for further considerations.
• Session organizers were identified.
• Each group of session organizers will submit a formal abstact (due Feb 27) to steering committee for final session selection.

If you have a talk you'd like to submit for consideration in any of these sessions, please contact us at fdaindustry2009@gmail.com and we will forward it to the appropriate session organizers

Sessions selected based on a vote:

1. PK-PD Analysis
2. Overview of Toxicology/Thorough QTC
3. Adaptive Design - Theory and Methods
4. Adaptive Design-Examples
5. Longitudinal Analysis and missing data
6. Future Directions in planning safety analysis and risk management
7. Quantitative Risk /Benefit Assessment
8. Global Harmonization -Regulatory
9. Global Harmonization -Statistical
10. Stat issues in phase I designs
11. Design Issues in Clinical Trials
12. Interim Analysis Futility Analyisis
13. Subgroup Heterogeneity/Adj of covariates
14. Survival Analysis
15. Stats Modeling , Simulation for decision Making
16. Bayesian
17. Multiplicities/Multiple Comparison
18. Meta Analysis
19. Non-Inferiority
20. Quality of Clinical Programs- Designs/Methodological/Robustness /Data
21. Biomarker/Genomics/Microarray
22. Open-source software/global platform
23. Oncology I - Issues
24. Oncology II. - Designs and Analysis
25. Psychiatric Clinical Trials CNS/Insomia
26. ICH Guidelines/ISS, ISE Anallysis Plans
27. Communication /Stats Consulting
28. CMC I
29. CMC II
30. Food
31. Veterinary Medicines I - Design and Analysis
32. Veterinary Medicines II - Issues
33. Devices I - Medical
34. Devices II - Diagnostics
35. Vaccines